Site Maintenance will take place from 4:00 PM on 2024-04-29 to 9:00 AM on 2024-05-01.
Please do not make any content change during this time, otherwise all the changes will be lost.

Select Publications

Journal articles

Varney B; Zoega H; Gillies MB; Gisev N; Weston Shand A; Pearson S-A; Havard A, 2024, 'Prevalence and Persistence of Prescription Opioid Use Following Hospital Discharge After Childbirth: An Australian Population-Based Cohort Study.', Anesth Analg, 138, pp. 970 - 979, http://dx.doi.org/10.1213/ANE.0000000000006582

de Oliveira Costa J; Lin J; Milder TY; Greenfield JR; Day RO; Stocker SL; Neuen BL; Havard A; Pearson S-A; Falster MO, 2024, 'Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia.', Diabetes Obes Metab, http://dx.doi.org/10.1111/dom.15597

Hopkins RE; Bharat C; Buizen L; Close J; Ivers R; Draper B; Pearson SA; Degenhardt L; Gisev N, 2024, 'Age-Related Risk of Serious Fall Events and Opioid Analgesic Use', JAMA Internal Medicine, 184, pp. 394 - 401, http://dx.doi.org/10.1001/jamainternmed.2023.8154

Bruno C; Cesta CE; Hjellvik V; Ulrichsen SP; Bjørk MH; Esen BÖ; Gillies MB; Gissler M; Havard A; Karlstad Ø; Leinonen MK; Nørgaard M; Pearson SA; Reutfors J; Furu K; Cohen JM; Zoega H, 2024, 'Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study', eClinicalMedicine, 70, http://dx.doi.org/10.1016/j.eclinm.2024.102531

Tran DT; Robijn AL; Varney B; Zoega H; Brew BK; Chambers GM; Falster K; Lingam R; Pearson SA; Havard A, 2024, 'Data Resource Profile: The Early Life Course data platform for research on perinatal and early childhood exposures and outcomes in Australia', International Journal of Epidemiology, 53, http://dx.doi.org/10.1093/ije/dyae045

Koch FC; Olivier J; Brett J; Buckley NA; Gisev N; Pearson S; Daniels B, 2024, 'The impact of tightened prescribing restrictions for PBS-subsidised opioid medicines and the introduction of half-pack sizes, Australia, 2020–21: an interrupted time series analysis', Medical Journal of Australia, 220, pp. 315 - 322, http://dx.doi.org/10.5694/mja2.52257

Stehlik P; Dowsett C; Camacho X; Falster MO; Lim R; Nasreen S; Pratt NL; Pearson SA; Henry D, 2024, 'Evolution of the data and methods in real-world COVID-19 vaccine effectiveness studies on mortality: A sc oping r eview protocol', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-079071

Jones AR; Currie D; Peng C; Ebeling PR; Center JR; Duque G; Lybrand S; Lyubomirsky G; Mitchell RJ; Pearson S; Seibel MJ; Occhipinti JA, 2024, 'Expanding access to fracture liaison services in Australia for people with minimal trauma fractures: a system dynamics modelling study', Medical Journal of Australia, 220, pp. 243 - 248, http://dx.doi.org/10.5694/mja2.52241

Ho C; Ha NT; Youens D; Abhayaratna WP; Bulsara MK; Hughes JD; Mishra G; Pearson SA; Preen DB; Reid CM; Ruiter R; Saunders CM; Stricker BH; van Rooij FJA; Wright C; Moorin R, 2024, 'Association between long-term use of calcium channel blockers (CCB) and the risk of breast cancer: a retrospective longitudinal observational study protocol', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-080982

Peiris D; Feyer AM; Barnard J; Billot L; Bouckley T; Campain A; Cordery D; de Souza A; Downey L; Elshaug AG; Ford B; Hanfy H; Hales L; Khalaj BH; Huckel Schneider C; Inglis J; Jan S; Jorm L; Landon B; Lujic S; Mulley J; Pearson SA; Schierhout G; Sivaprakash P; Stanton C; Stephens A; Willcox D, 2024, 'Overcoming silos in health care systems through meso-level organisations – a case study of health reforms in New South Wales, Australia', The Lancet Regional Health - Western Pacific, 44, http://dx.doi.org/10.1016/j.lanwpc.2024.101013

Koch FC; Tang M; Walpola R; Aslam M; Pearson S-A; Daniels B, 2024, 'Changes in systemic cancer therapy in Australia during the Delta and Omicron waves of the COVID-19 pandemic (2021-2022): a controlled interrupted time series analysis.', Public Health Res Pract, http://dx.doi.org/10.17061/phrp34012402

Lord SJ; Daniels B; O'Connell DL; Kiely BE; Beith J; Smith AL; Pearson SA; Chiew KL; Bulsara MK; Houssami N, 2024, 'Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001-2016', Cancer Epidemiology Biomarkers and Prevention, 33, pp. 314 - 324, http://dx.doi.org/10.1158/1055-9965.EPI-23-0942

Neuen BL; Heerspink HJL; Vart P; Claggett BL; Fletcher RA; Arnott C; de Oliveira Costa J; Falster MO; Pearson SA; Mahaffey KW; Neal B; Agarwal R; Bakris G; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria', Circulation, 149, pp. 450 - 462, http://dx.doi.org/10.1161/CIRCULATIONAHA.123.067584

Ali S; Coory M; Donovan P; Na R; Pandeya N; Pearson SA; Spilsbury K; Stewart LM; Thompson B; Tuesley K; Waterhouse M; Webb PM; Jordan SJ; Neale RE, 2024, 'Association between unstable diabetes mellitus and risk of pancreatic cancer', Pancreatology, 24, pp. 66 - 72, http://dx.doi.org/10.1016/j.pan.2023.11.009

Ali S; Coory M; Donovan P; Na R; Pandeya N; Pearson S-A; Spilsbury K; Stewart L; Thompson B; Tuesley K; Waterhouse M; Webb P; Jordan S; Neale R, 2024, 'Abstract A009: Association between unstable diabetes mellitus and risk of pancreatic cancer', Cancer Research, 84, pp. A009 - A009, http://dx.doi.org/10.1158/1538-7445.panca2023-a009

Brikell I; Yao H; Li L; Astrup A; Gao L; Gillies MB; Xie T; Zhang-James Y; Dalsgaard S; Engeland A; Faraone SV; Haavik J; Hartman C; Ip P; Jakobsdóttir Smári U; Larsson H; Man KK; de Oliveira Costa J; Pearson SA; Hostrup Nielsen NP; Snieder H; Wimberley T; Wong IC; Zhang L; Zoega H; Klungsøyr K; Chang Z, 2024, 'ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases', The Lancet Psychiatry, 11, pp. 16 - 26, http://dx.doi.org/10.1016/S2215-0366(23)00332-2

Lord SJ; Kiely BE; O'Connell DL; Daniels B; Beith J; Smith AL; Pearson SA; Chiew KL; Bulsara MK; Houssami N, 2024, 'Characteristics and post-metastasis survival of recurrent metastatic breast cancer over time – An Australian population-based record linkage study, 2001–2016', European Journal of Cancer, 197, http://dx.doi.org/10.1016/j.ejca.2023.113468

Gillies MB; Camacho X; Bharat C; Buizen L; Blyth F; Currow D; Wilson A; Degenhardt L; Gisev N; Pearson SA, 2024, 'Oxycodone initiation in Australia (2014–2018): Sociodemographic factors and preceding health service use', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.16063

Ali S; Coory M; Donovan P; Na R; Pandeya N; Pearson SA; Spilsbury K; Tuesley K; Jordan SJ; Neale RE, 2024, 'Predicting the risk of pancreatic cancer in women with new-onset diabetes mellitus', Journal of Gastroenterology and Hepatology (Australia), http://dx.doi.org/10.1111/jgh.16503

Camacho X; Schaffer AL; Brett J; Pratt N; Buckley NA; Henry D; Pearson SA, 2024, 'Quality use of publicly subsidised tapentadol in Australia: a population-based analysis', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.16335

Tran DT; Falster MO; Pearse J; Mazevska D; McElduff P; Pearson S; van Gool KC; Hall J; Jorm L, 2024, 'The Australian Health Care Homes trial: quality of care and patient outcomes. A propensity score-matched cohort study', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.52266

Yu J; Arnott C; Li Q; Di Tanna GL; Tian M; Huang L; Yin X; Zhang X; Pearson S-A; Labarthe DR; Elliott P; Yan LL; Zhou B; Wu Y; Neal B, 2024, 'Secondary Analysis of the Salt Substitute and Stroke Study (SSaSS): Effects of Potassium-Enriched Salt on Cardiac Outcomes.', Hypertension, 81, pp. 1031 - 1040, http://dx.doi.org/10.1161/HYPERTENSIONAHA.123.22410

de Oliveira Costa J; Pearson SA; Brieger D; Lujic S; Shawon MSR; Jorm LR; van Gool K; Falster MO, 2023, 'In-hospital outcomes by insurance type among patients undergoing percutaneous coronary interventions for acute myocardial infarction in New South Wales public hospitals', International Journal for Equity in Health, 22, pp. 226, http://dx.doi.org/10.1186/s12939-023-02030-1

Liu B; Stepien S; Dobbins T; Gidding H; Henry D; Korda R; Mills L; Pearson SA; Pratt N; Vajdic CM; Welsh J; Macartney K, 2023, 'Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study', The Lancet Regional Health - Western Pacific, 40, http://dx.doi.org/10.1016/j.lanwpc.2023.100928

Brett J; Gillies MB; Buckley NA; Pearson SA; Zoega H, 2023, 'Patterns of suboptimal antipsychotic use and misuse in Australia: What can routinely collected data tell us?', British Journal of Clinical Pharmacology, 89, pp. 3411 - 3420, http://dx.doi.org/10.1111/bcp.15821

Tuesley KM; Spilsbury K; Webb PM; Protani MM; Dixon-Suen S; Pearson SA; Donovan P; Coory MD; Steer CB; Stewart LM; Pandeya N; Jordan SJ, 2023, 'Association between antihypertensive medicine use and risk of ovarian cancer in women aged 50 years and older', Cancer Epidemiology, 86, http://dx.doi.org/10.1016/j.canep.2023.102444

Daniels B; Aslam M; van Leeuwen MT; Brown M; Hunt L; Gurney H; Tang M; Pearson SA; Vajdic CM, 2023, 'Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort study', The Lancet Regional Health - Western Pacific, 39, pp. 100872, http://dx.doi.org/10.1016/j.lanwpc.2023.100872

Hansford HJ; Cashin AG; Jones MD; Swanson SA; Islam N; Douglas SRG; Rizzo RRN; Devonshire JJ; Williams SA; Dahabreh IJ; Dickerman BA; Egger M; Garcia-Albeniz X; Golub RM; Lodi S; Moreno-Betancur M; Pearson SA; Schneeweiss S; Sterne JAC; Sharp MK; Stuart EA; Hernán MA; Lee H; McAuley JH, 2023, 'Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic Review', JAMA Network Open, 6, pp. E2336023, http://dx.doi.org/10.1001/jamanetworkopen.2023.36023

Hansford HJ; Cashin AG; Jones MD; Swanson SA; Islam N; Dahabreh IJ; Dickerman BA; Egger M; Garcia-Albeniz X; Golub RM; Lodi S; Moreno-Betancur M; Pearson SA; Schneeweiss S; Sterne J; Sharp MK; Stuart EA; Hernan MA; Lee H; McAuley JH, 2023, 'Development of the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guideline', BMJ Open, 13, pp. e074626, http://dx.doi.org/10.1136/bmjopen-2023-074626

Leung J; Chiu V; Man N; Yuen WS; Dobbins T; Dunlop A; Gisev N; Hall W; Larney S; Pearson SA; Degenhardt L; Peacock A, 2023, 'All-cause and cause-specific mortality in individuals with an alcohol-related emergency or hospital inpatient presentation: A retrospective data linkage cohort study', Addiction, 118, pp. 1751 - 1762, http://dx.doi.org/10.1111/add.16218

Sotade OT; Falster MO; Pearson SA; Jorm LR; Sedrakyan A, 2023, 'Comparison of long-term outcomes of bioprosthetic and mechanical aortic valve replacement in patients younger than 65 years', Journal of Thoracic and Cardiovascular Surgery, 166, pp. 728 - 737.e13, http://dx.doi.org/10.1016/j.jtcvs.2022.01.016

Raphelson JR; Ahmed IM; Ancoli-Israel S; Ojile J; Pearson S; Bennett N; Uhles ML; Rohrscheib C; Malhotra A, 2023, 'Evaluation of a novel device to assess obstructive sleep apnea and body position', Journal of Clinical Sleep Medicine, 19, pp. 1643 - 1649, http://dx.doi.org/10.5664/jcsm.10644

Havard A; Jones N; Bharat C; Gisev N; Pearson SA; Shakeshaft A; Farrell M; Degenhardt L, 2023, 'Mortality during and after specialist alcohol and other drug treatment: Variation in rates according to principal drug of concern and treatment modality', Drug and Alcohol Review, 42, pp. 1461 - 1471, http://dx.doi.org/10.1111/dar.13669

Schaffer AL; Gisev N; Blyth FM; Buckley NA; Currow D; Dobbins TA; Wilson A; Degenhardt L; Pearson SA, 2023, 'Opioid prescribing patterns among medical practitioners in New South Wales, Australia', Drug and Alcohol Review, 42, pp. 1472 - 1481, http://dx.doi.org/10.1111/dar.13675

Lin J; Pearson SA; Greenfield JR; Park KH; Havard A; Brieger D; Day RO; Falster MO; de Oliveira Costa J, 2023, 'Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)', European Journal of Clinical Pharmacology, 79, pp. 1239 - 1248, http://dx.doi.org/10.1007/s00228-023-03539-8

Gisev N; Buizen L; Hopkins RE; Schaffer AL; Daniels B; Bharat C; Dobbins T; Larney S; Blyth F; Currow DC; Wilson A; Pearson SA; Degenhardt L, 2023, 'Five-Year Trajectories of Prescription Opioid Use', JAMA Network Open, 6, pp. E2328159, http://dx.doi.org/10.1001/jamanetworkopen.2023.28159

Chitty KM; Buckley NA; Lim J; Ali Z; Schumann JL; Cairns R; Daniels B; Pearson SA; Preen DB; Schaffer AL, 2023, 'Psychotropic and other medicine use at time of death by suicide: a population-level analysis of linked dispensing and forensic toxicology data', Medical Journal of Australia, 219, pp. 63 - 69, http://dx.doi.org/10.5694/mja2.51985

Costa JDO; Lin J; Pearson SA; Buckley NA; Schaffer AL; Falster MO; de Oliveira Costa J, 2023, 'Persistence and Adherence to Cardiovascular Medicines in Australia', Journal of the American Heart Association, 12, pp. e030264, http://dx.doi.org/10.1161/JAHA.122.030264

Robijn AL; Filion KB; Woodward M; Hsu B; Chow CK; Pearson SA; Jorm L; Falster MO; Havard A, 2023, 'Comparative effect of varenicline and nicotine patches on preventing repeat cardiovascular events', Heart, 109, pp. 1016 - 1024, http://dx.doi.org/10.1136/heartjnl-2022-322170

Bruno C; Zoega H; Gillies MB; Havard A; Coghill D; Pearson SA; Brett J, 2023, 'Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysis', Australian and New Zealand Journal of Psychiatry, 57, pp. 1073 - 1076, http://dx.doi.org/10.1177/00048674231170556

Wilson BE; Booth CM; Sullivan R; Aggarwal A; Sengar M; Jacob S; Bray F; Barton MB; Pearson SA, 2023, 'Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurement', The Lancet Oncology, 24, pp. 682 - 690, http://dx.doi.org/10.1016/S1470-2045(23)00183-3

Tang M; Daniels B; Coory M; Pearson SA, 2023, 'Timely and comprehensive real-world data for optimizing lung cancer treatment and outcomes for Australians', Asia-Pacific Journal of Clinical Oncology, 19, pp. 413 - 414, http://dx.doi.org/10.1111/ajco.13874

Gisev N; Pearson SA; Dobbins T; Buizen L; Murphy T; Wilson A; Blyth F; Dunlop A; Larney S; Currow DC; Mattick RP; Degenhardt L, 2023, 'Cohort profile: POPPY II - A population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-068310

Bruno C; Havard A; Gillies MB; Coghill D; Brett J; Guastella AJ; Pearson SA; Zoega H, 2023, 'Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013–2020)', Australian and New Zealand Journal of Psychiatry, 57, pp. 675 - 685, http://dx.doi.org/10.1177/00048674221114782

de Oliveira Costa J; Lau S; Medland N; Gibbons S; Schaffer AL; Pearson SA, 2023, 'Potential drug–drug interactions due to concomitant medicine use among people living with HIV on antiretroviral therapy in Australia', British Journal of Clinical Pharmacology, 89, pp. 1541 - 1553, http://dx.doi.org/10.1111/bcp.15614

Bharat C; Degenhardt L; Pearson SA; Buizen L; Wilson A; Dobbins T; Gisev N, 2023, 'A data-informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data', Pharmacoepidemiology and Drug Safety, 32, pp. 352 - 365, http://dx.doi.org/10.1002/pds.5567

Lopez D; Strange C; Sanfilippo F; Daniels B; Pearson S; Preen D, 2023, 'Priorities for building Australian workforce capacity to leverage population-based, routinely collected data: views from pharmacoepidemiology', Public Health Research and Practice, 33, http://dx.doi.org/10.17061/phrp32122206

Tang M; Pearson SA; Simes RJ; Chua BH, 2023, 'Harnessing Real-World Evidence to Advance Cancer Research', Current Oncology, 30, pp. 1844 - 1859, http://dx.doi.org/10.3390/curroncol30020143

Spilsbury K; Tuesley KM; Pearson SA; Coory MD; Donovan P; Steer CB; Stewart LM; Pandeya N; Jordan SJ, 2023, 'Perioperative Beta-Blocker Supply and Survival in Women with Epithelial Ovarian Cancer and a History of Cardiovascular Conditions', Journal of Clinical Oncology, 41, pp. 266 - 275, http://dx.doi.org/10.1200/JCO.22.00097

Ahmed S; Pollack A; Havard A; Pearson SA; Chidwick K, 2023, 'Agreement of acute serious events recorded across datasets using linked Australian general practice, hospital, emergency department and death data: implications for research and surveillance', International Journal of Population Data Science, 8, http://dx.doi.org/10.23889/ijpds.v8i1.2118


Back to profile page